Constitutional epimutations in hereditary cancer predisposition

Megan Hitchins

Cedars-Sinai Medical Center



Aula Taronja (edifici Jardí)


Megan Hitchins – Department of Biomedical Sciences, Cedars-Sinai Medical Center
Dr. Megan Hitchins undertakes translational cancer research with a focus on genetic and epigenetic alterations associated with cancer, in particular cancer-specific changes in DNA methylation. Researchers in the Hitchins Lab undertake studies on genetic and epigenetic alterations that predispose to cancer onset, as well as the discovery and development of epigenetic alterations to serve as tumor biomarkers for applications to cancer diagnosis, prognosis or prediction of treatment outcomes.

Hosted by Gabriel Capellá – Hereditary Cancer group


Scroll to Top